Stockscreener 앱 받기
183.41
1.61%
-2.816
전일 마감가:
$186.23
열려 있는:
$185.28
하루 거래량:
1.48M
Relative Volume:
0.60
시가총액:
$38.72B
수익:
$447.02M
순이익/손실:
$-1.18B
주가수익비율:
-29.67
EPS:
-6.1812
순현금흐름:
$-868.57M
1주 성능:
+10.86%
1개월 성능:
+16.59%
6개월 성능:
+153.44%
1년 성능:
+169.11%
1일 변동 폭
$183.00
$187.88
1주일 범위
$163.82
$197.08
52주 변동 폭
$60.40
$197.08
Insmed Inc Stock (INSM) Company Profile
명칭
Insmed Inc
전화
908-977-9900
주소
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
INSM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
183.13 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.50 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.24 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.88 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
836.39 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-28 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-10-20 | 개시 | Wells Fargo | Overweight |
| 2025-08-20 | 개시 | William Blair | Outperform |
| 2025-08-13 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | 개시 | Jefferies | Buy |
| 2025-02-25 | 개시 | RBC Capital Mkts | Outperform |
| 2024-04-23 | 개시 | Truist | Buy |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2023-12-08 | 개시 | Wells Fargo | Overweight |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-07-26 | 개시 | Guggenheim | Buy |
| 2022-12-09 | 개시 | Mizuho | Buy |
| 2022-12-07 | 개시 | Barclays | Overweight |
| 2022-11-18 | 개시 | BofA Securities | Buy |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2021-12-06 | 개시 | JP Morgan | Overweight |
| 2021-10-19 | 재개 | Monness Crespi & Hardt | Buy |
| 2021-10-19 | 재개 | Morgan Stanley | Overweight |
| 2021-10-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-10-12 | 재개 | Stifel | Buy |
| 2019-09-03 | 개시 | Goldman | Buy |
| 2019-04-09 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-15 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-01-02 | 개시 | Canaccord Genuity | Buy |
| 2018-08-06 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | 개시 | Goldman | Neutral |
| 2018-04-23 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | 개시 | Morgan Stanley | Overweight |
| 2018-01-18 | 개시 | Credit Suisse | Neutral |
| 2017-09-05 | 재확인 | Evercore ISI | Outperform |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-07-11 | 개시 | Robert W. Baird | Outperform |
| 2016-03-15 | 개시 | Stifel | Buy |
| 2015-11-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2015-10-06 | 재확인 | H.C. Wainwright | Buy |
| 2015-06-09 | 개시 | Citigroup | Neutral |
| 2014-03-26 | 재확인 | HC Wainwright | Buy |
모두보기
Insmed Inc 주식(INSM)의 최신 뉴스
3,909 Shares in Insmed, Inc. $INSM Purchased by Corton Capital Inc. - MarketBeat
Why Insmed Incorporated is moving todayWeekly Stock Recap & Weekly Breakout Watchlists - newser.com
Will Insmed Incorporated stock benefit from automationTrend Reversal & Stepwise Swing Trade Plans - newser.com
Trend analysis for Insmed Incorporated this week2025 Breakouts & Breakdowns & Technical Confirmation Alerts - newser.com
Can Insmed Incorporated stock deliver surprise earnings beatPortfolio Risk Summary & Fast Moving Trade Plans - newser.com
Assetmark Inc. Acquires 5,892 Shares of Insmed, Inc. $INSM - MarketBeat
Nisa Investment Advisors LLC Sells 1,556 Shares of Insmed, Inc. $INSM - MarketBeat
How Insmed Incorporated (IM8N) stock compares with tech leadersQuarterly Earnings Summary & Reliable Price Breakout Signals - newser.com
What machine learning models say about Insmed Incorporated2025 Investor Takeaways & Safe Investment Capital Preservation Plans - newser.com
What indicators show strength in Insmed Incorporated2025 Technical Overview & Free Weekly Watchlist of Top Performers - newser.com
Insmed Incorporated (INSM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Building trade automation scripts for Insmed IncorporatedBuy Signal & Technical Pattern Based Signals - newser.com
Approval of Brinsupri Lifted Insmed Incorporated (INSM) in Q3 - Yahoo Finance
Insmed discovers new cathepsin C inhibitors - BioWorld MedTech
Is Insmed Incorporated (IM8N) stock a buy before new product rollout2025 Market Outlook & Weekly High Momentum Picks - newser.com
Historical volatility pattern of Insmed Incorporated visualized2025 Historical Comparison & Stepwise Swing Trade Plans - newser.com
How Insmed Incorporated stock reacts to Fed rate cutsGap Down & Daily Profit Maximizing Tips - newser.com
Insmed Incorporated stock volume spike explainedJuly 2025 Volume & Fast Gain Swing Trade Alerts - newser.com
Earnings Beat: Insmed Incorporated (NASDAQ:INSM) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Yahoo Finance
What dividend safety score for Insmed Incorporated stock2025 Geopolitical Influence & Low Risk Entry Point Tips - newser.com
Insmed, Inc. $INSM Position Reduced by Moody Aldrich Partners LLC - MarketBeat
Envestnet Asset Management Inc. Acquires 40,520 Shares of Insmed, Inc. $INSM - MarketBeat
Teacher Retirement System of Texas Has $4.93 Million Stake in Insmed, Inc. $INSM - MarketBeat
Insmed Incorporated (NASDAQ:INSM) Q3 2025 Earnings Call Transcript - Insider Monkey
Wells Fargo Maintains Insmed (INSM) Overweight Recommendation - Nasdaq
Insmed Inc (INSM) Stock Price, Trades & News - GuruFocus
Insmed (NASDAQ:INSM) Posts Earnings Results, Misses Estimates By $0.40 EPS - MarketBeat
Wells Fargo Raises Price Target for INSM to $217, Maintains Over - GuruFocus
Goldman Sachs Maintains Insmed (INSM) Buy Recommendation - Nasdaq
Wells Fargo Raises Price Target for INSM to $217, Maintains Overweight Rating | INSM Stock News - GuruFocus
Insmed (NASDAQ:INSM) Hits New 12-Month HighTime to Buy? - MarketBeat
Insmed Misses on Q3 Earnings, Stock Rises on Strong Brinsupri Uptake - sharewise.com
Goldman Sachs Boosts Insmed (INSM) Price Target to $225 | INSM Stock News - GuruFocus
INSM: UBS Maintains 'Buy', Raises Price Target to $223 | INSM St - GuruFocus
Insmed Shares Likely to Gain From Brinsupri Sales, Untapped Pipeline, UBS Says - MarketScreener
Insmed stock surges as UBS raises price target on Brinsupri launch success - Investing.com Canada
Insmed (INSM) Sees Price Target Raised by RBC Capital to $215 | - GuruFocus
Insmed (INSM) Hits All-Time High as Firm Posts Highly Optimistic Outlook - Insider Monkey
Insmed Q3 2025 slides reveal strong BRINSUPRI debut, ARIKAYCE growth accelerates - Investing.com Australia
Insmed stock hits 52-week high at 170.3 USD By Investing.com - Investing.com Australia
RBC Raises Price Target on Insmed to $215 From $139, Keeps Outperform Rating - MarketScreener
Cantor Fitzgerald Comments on Insmed FY2025 Earnings - MarketBeat
UBS Adjusts Insmed Price Target to $223 From $194, Maintains Buy Rating - MarketScreener
Truist Raises Price Target on Insmed to $214 From $139, Keeps Buy Rating - MarketScreener
Insmed: Q3 Earnings Snapshot - Stamford Advocate
Emerald Mutual Fund Advisers Trust Sells 328,407 Shares of Insmed, Inc. $INSM - MarketBeat
Emerald Advisers LLC Decreases Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed Reaches Analyst Target Price - Nasdaq
Insmed, Inc. $INSM Shares Sold by Jennison Associates LLC - MarketBeat
Biotech Stocks Hit 52-Week Highs: MTSR, INSM, ABVX, MAZE Lead October 30 Surge - RTTNews
Is Insmed Incorporated (IM8N) stock among top earnings playsPortfolio Gains Summary & AI Optimized Trading Strategy Guides - newser.com
Insmed Inc (INSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Insmed Inc 주식 (INSM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Schaeffer Orlov S Nicole | Chief People Strategy Officer |
Sep 12 '25 |
Option Exercise |
23.75 |
56,520 |
1,342,350 |
112,981 |
| Schaeffer Orlov S Nicole | Chief People Strategy Officer |
Sep 12 '25 |
Sale |
145.45 |
76,520 |
11,129,927 |
36,461 |
| SHAROKY MELVIN MD | Director |
Sep 12 '25 |
Sale |
145.39 |
10,000 |
1,453,900 |
262,675 |
0.29%
1.30%
자본화:
|
볼륨(24시간):